It's the end of the year already and I hope you are looking forward to the festive period and the opportunity to wind down and spend some quality time with family and friends.
It's the end of the year already and I hope you are looking forward to the festive period and the opportunity to wind down and spend some quality time with family and friends. I'm certainly looking forward to filling my house with too many decorations and having an excuse to over-indulge on good food and wine (I have no excuses during the rest of the year!).
Fedra Pavlou
I just wanted to take this opportunity to thank you for a fulfilling and eventful first year as Editor of Pharmaceutical Technology Europe (PTE). The feedback that I have received from readers and industry has proven to me that PTE is indeed a well-regarded and respected publication and I am proud to be a part of it. Thank you to everybody that has taken the time to meet with me at the various meetings that our team has attended this year; it has been a real pleasure. Thank you also to those of you who have joined our LinkedIn (www.pharmtech.com/linkedin) and Twitter (www.pharmtech.com/twitter) groups. It has been incredibly rewarding to see the number of members of our various networking groups growing day-by-day and to see our readers interacting with us and with each other. I also hope that you have enjoyed using our new website, which launched this summer (www.pharmtech.com). As always, I would welcome any comments that you have to make on our website and our publications, so please do feel free to email me or to post a discussion on our LinkedIn group; your opinions are of the utmost importance to me and to the rest of the PTE team.
I would now like to take this opportunity to wish you happy holidays and to thank you for your continued support of our publication throughout the year. Let's look forward to a happy and successful 2010!
Best wishes,
Fedra Pavlou
Editor-in-Chief
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.